Advertisement
Singapore markets close in 7 hours 22 minutes
  • Straits Times Index

    3,285.48
    -2.27 (-0.07%)
     
  • Nikkei

    37,677.09
    +48.61 (+0.13%)
     
  • Hang Seng

    17,336.20
    +51.66 (+0.30%)
     
  • FTSE 100

    8,078.86
    +38.48 (+0.48%)
     
  • Bitcoin USD

    64,213.90
    -338.28 (-0.52%)
     
  • CMC Crypto 200

    1,381.71
    -0.87 (-0.06%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • Dow

    38,085.80
    -375.12 (-0.98%)
     
  • Nasdaq

    15,611.76
    -100.99 (-0.64%)
     
  • Gold

    2,341.50
    -1.00 (-0.04%)
     
  • Crude Oil

    83.77
    +0.20 (+0.24%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • FTSE Bursa Malaysia

    1,568.65
    -0.60 (-0.04%)
     
  • Jakarta Composite Index

    7,155.29
    -7,174.53 (-50.07%)
     
  • PSE Index

    6,574.88
    0.00 (0.00%)
     

Exploring Depomed’s Financial Performance Today

Exploring Depomed’s Financial Performance Today

In fiscal 2017, Depomed (DEPO) generated total revenues of $380.7 million. Of these total revenues, $379.8 million came from product sales, and ~$844,000 came from royalties. By comparison, the company had generated total revenues of $455.8 million in fiscal 2016, of which $455 million came from product sales and $831 million from royalties.